Artículos por temáticas

Initiation of Parkinson's disease from gut to brain by δ-secretase

Ahn EH, Kang SS, Liu X, Chen G, Zhang Z, Chandrasekharan B, Alam AM, Neish AS, Cao X, Ye K.

Cell Res. 2020 Jan;30(1):70-87. doi: 10.1038/s41422-019-0241-9. Epub 2019 Oct 24.

Managing Parkinson's disease: moving ON with NOP

Mercatelli D, Bezard E, Eleopra R, Zaveri NT, Morari M.

Br J Pharmacol. 2020 Jan;177(1):28-47. doi: 10.1111/bph.14893. Epub 2020 Jan 3.

Multimodal Training Reduces Fall Frequency as Physical Activity Increases in Individuals With Parkinson's Disease.

Penko AL, Barkley JE, Rosenfeldt AB, Alberts JL.

J Phys Act Health. 2019 Oct 24:1-7. doi: 10.1123/jpah.2018-0595. [Epub ahead of print]

Power vs strength training to improve muscular strength, power, balance and functional movement in individuals diagnosed with Parkinson's disease.

Cherup NP, Buskard ANL, Strand KL, Roberson KB, Michiels ER, Kuhn JE, Lopez FA, Signorile JF.

Exp Gerontol. 2019 Oct 21;128:110740. doi: 10.1016/j.exger.2019.110740. [Epub ahead of print]

Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease

Biswas S, Roy R, Biswas R, Bagchi A.

Gene. 2020 Feb 5;726:144186. doi: 10.1016/j.gene.2019.144186. Epub 2019 Oct 21.

Neuropsychiatric symptoms in Parkinson's disease: association with caregiver distress and disease severity.

Tsai WC, Lin HC, Chang CC, Chang WN, Huang CC, Cheng KY, Wang HC, Lin WC, Hsiao SY, Lai YR, Lu CH, Tsai NW.

Int Psychogeriatr. 2019 Oct 24:1-7. doi: 10.1017/S1041610219001510. [Epub ahead of print]

Biomarkers for Parkinson's Disease: How Good Are They?

Li T, Le W.

Neurosci Bull. 2020 Feb;36(2):183-194. doi: 10.1007/s12264-019-00433-1. Epub 2019 Oct 23.

A phase 2, open-label, multi-center study to evaluate the efficacy and safety of (99m)Tc-TRODAT-1 SPECT to detect Parkinson's disease

Sun Y, Liu C, Chen Z, Li B, Lv Z, Lou J, Tang J, Wang Y, Zhang G, Liu X.

Ann Nucl Med. 2020 Jan;34(1):31-37. doi: 10.1007/s12149-019-01412-2. Epub 2019 Oct 23.

[Research progress on neural mechanism of peripheral inflammation in Parkinson's disease].

Liu YT, Sun MH, Cai CW, Ren C, Niu HC.

Sheng Li Xue Bao. 2019 Oct 25;71(5):732-740. Chinese.

Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease.

Kaidery NA, Ahuja M, Thomas B.

Mol Cell Neurosci. 2019 Oct 20:103413. doi: 10.1016/j.mcn.2019.103413. [Epub ahead of print] Review.

Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease

Pak ME, Ahn SM, Jung DH, Lee HJ, Ha KT, Shin HK, Choi BT.

J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):712-721. doi: 10.1093/gerona/glz256.

Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.

Yoo HS, Choi YH, Chung SJ, Lee YH, Ye BS, Sohn YH, Lee JM, Lee PH.

Ann Clin Transl Neurol. 2019 Oct 23. doi: 10.1002/acn3.50918. [Epub ahead of print]

Are genetic and idiopathic forms of Parkinson's disease the same disease?

Correia Guedes L, Mestre T, Outeiro TF, Ferreira JJ.

J Neurochem. 2020 Mar;152(5):515-522. doi: 10.1111/jnc.14902. Epub 2019 Dec 8.

Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson's disease

Yonguc T, Sefik E, Inci I, Kusbeci OY, Celik S, Aydın ME, Polat S.

World J Urol. 2020 Aug;38(8):2013-2019. doi: 10.1007/s00345-019-02981-7. Epub 2019 Oct 23.

IRE1 promotes neurodegeneration through autophagy-dependent neuron death in the Drosophila model of Parkinson's disease.

Yan C, Liu J, Gao J, Sun Y, Zhang L, Song H, Xue L, Zhan L, Gao G, Ke Z, Liu Y, Liu J.

Cell Death Dis. 2019 Oct 22;10(11):800. doi: 10.1038/s41419-019-2039-6.